PostEra is using our Protonplatform to develop cures for diseases via an internal drug discovery pipeline and also through co-discovery with external partners.

hero-image
smooth-image
smooth-image

The PostEra Pipeline

IndicationEarly DiscoveryLate DiscoveryIND-EnablingClinicPartnerRights
COVID
Moonshot
Non-profit
COVID
Pfizer
Royalties + Milestones
Pandemic Preparedness
NIH
Non-profit
Oncology
Pfizer
Royalties + Milestones
Coming Soon
Internal
Wholly-Owned

CO-DISCOVERY

We partner with organizations to develop small molecule drug candidates.

Here’s how we typically work

01

Biopharma partner selects biological targets and helps define the assay cascade and Target-Product-Profile.

02

PostEra drives the discovery of safe and effective small molecules against those targets until the nomination of Development Candidate(s).

03

The Partner and PostEra agree on who shall sponsor the asset into IND-enabling studies and the Clinic.

Our Drug Discovery Partners

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to close the Design-Make-Test cycle of medicinal chemistry and bring more cures to patients.

Stay up to date with our Newsletter

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to close the Design-Make-Test cycle of medicinal chemistry and bring more cures to patients.

Terms & Conditions

© 2022 PostEra